DE69535156D1 - Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion - Google Patents

Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion

Info

Publication number
DE69535156D1
DE69535156D1 DE69535156T DE69535156T DE69535156D1 DE 69535156 D1 DE69535156 D1 DE 69535156D1 DE 69535156 T DE69535156 T DE 69535156T DE 69535156 T DE69535156 T DE 69535156T DE 69535156 D1 DE69535156 D1 DE 69535156D1
Authority
DE
Germany
Prior art keywords
rochalimaea
subject
henselae
diagnosing
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535156T
Other languages
English (en)
Other versions
DE69535156T2 (de
Inventor
L Regnery
E Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/245,294 external-priority patent/US5644047A/en
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of DE69535156D1 publication Critical patent/DE69535156D1/de
Application granted granted Critical
Publication of DE69535156T2 publication Critical patent/DE69535156T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69535156T 1994-05-18 1995-05-18 Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion Expired - Lifetime DE69535156T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US245294 1994-05-18
US08/245,294 US5644047A (en) 1992-01-17 1994-05-18 Compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
US08/307,279 US5736347A (en) 1992-01-17 1994-09-16 Nucleic acids of Rochalimaea henselae and methods and compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infection
US307279 1994-09-16
PCT/US1995/006211 WO1995031549A1 (en) 1994-05-18 1995-05-18 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection

Publications (2)

Publication Number Publication Date
DE69535156D1 true DE69535156D1 (de) 2006-09-21
DE69535156T2 DE69535156T2 (de) 2007-08-16

Family

ID=26937129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535156T Expired - Lifetime DE69535156T2 (de) 1994-05-18 1995-05-18 Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion

Country Status (8)

Country Link
US (1) US5736347A (de)
EP (1) EP0759988B1 (de)
JP (1) JP3689426B2 (de)
AT (1) ATE335821T1 (de)
AU (1) AU699416B2 (de)
CA (1) CA2190359C (de)
DE (1) DE69535156T2 (de)
WO (1) WO1995031549A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958414A (en) * 1997-09-03 1999-09-28 Heska Corporation Composition to protect a mammal against Bartonella henselae infection
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
WO2000031270A1 (en) * 1998-11-19 2000-06-02 The Government Of The United States Of America Represented By The Secretary Of The Department Of Health And Human Services Bartonella proteins and uses thereof
FR2791357B1 (fr) * 1999-03-26 2003-05-16 Didier Raoult Diagnostic de la maladie de whipple
US20030165526A1 (en) * 1999-09-17 2003-09-04 Kuzyk Michael A. Vaccines and agents for inducing immunity against rickettsial diseases, and associated preventative therapy
NO329958B1 (no) * 1999-09-17 2011-01-31 Pfizer Canada Inc Anvendelse av en immunogen mengde av OspA-lipoprotein fra Piscirickettsia salmonis, OspA-antigen, og immunogene promiskuose TCE i et OspA-kimaert fusjonsprotein, for fremstilling av medikamenter, og immunologisk in vitro-fremgangsmate for deteksjon av humoralt antistoff mot OspA eller P. salmonis.
US20040131631A1 (en) * 2002-11-22 2004-07-08 Alexander Andrianov Polyphosphazene immunostimulants
WO2010021849A2 (en) * 2008-08-22 2010-02-25 Medical Diagnostic Laboratories, Llc Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399485A (en) * 1992-01-17 1995-03-21 United States Of America Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae

Also Published As

Publication number Publication date
AU699416B2 (en) 1998-12-03
CA2190359A1 (en) 1995-11-23
DE69535156T2 (de) 2007-08-16
EP0759988B1 (de) 2006-08-09
CA2190359C (en) 2010-03-02
US5736347A (en) 1998-04-07
EP0759988A1 (de) 1997-03-05
JPH10507902A (ja) 1998-08-04
WO1995031549A1 (en) 1995-11-23
AU2592995A (en) 1995-12-05
ATE335821T1 (de) 2006-09-15
JP3689426B2 (ja) 2005-08-31

Similar Documents

Publication Publication Date Title
Hanff et al. Humoral immune response in human syphilis to polypeptides of Treponema pallidum.
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
RU99125615A (ru) Антигенные сайты вррсс, определяющие последовательности белков вируса ррсс, пригодные для использования в вакцинах или в диагностике
UA42668C2 (uk) Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти)
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
ATE469222T1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
Hirschmann et al. Pneumococcal vaccine in the United States: a critical analysis
DE69616777D1 (de) Verbindungen und verfahren zur diagnose von leishmaniasis
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
DK524289D0 (da) Fremgangsmaade til diagnosticering for og vaccine mod mycobakterier
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion
DE69331377D1 (de) Verfahren und zusammensetzungen zur diagnose der katzenkratzkrankheit und der bakteriellen angiomatose
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
Vestergaard Production of antiserum against a specific herpes simplex virus type 2 antigen
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
CN106596964B (zh) 用于诊断蠕虫感染的新型测定
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
HU906639D0 (en) Diagnostic process for detecting htlv-i peptides and their antibodies causing infection, and vaccine for treating the disease
CA2109822A1 (en) Diagnostic peptides derived from m.tuberculosis antigens
HK1014547A1 (en) Rabbit hemorrhagic disease virus (rhdv) recombinant capsids and proteins, diagnostic kits and vaccines containing them.
Wicher et al. Cell response in rabbits infected with T. pallidum as measured by the leucocyte migration inhibition test.
HUP0102730A2 (hu) Neisseria meningitidis antigén tulajdonságú polipeptidek, megfelelő polinuklotidok és védelmet nyújtó ellenanyagok
Coffey et al. Experimental Relapsing Fever Initiated by Borrelia hermsi: I. Identification of Major Serotypes by Immunofluorescence
DE69521985D1 (de) Diagnose und behandlung von streptococus oder enterococus infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition